ONWARD Reports Q1 Business Update and Year-To-Date Highlights
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending... | May 16, 2023
Source: marketscreener.com